Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
Valion Bio announced that the U.S. government is funding studies through AFRRI/NIAID to evaluate Entolimod for radiation-induced gastrointestinal (GI) injury. These studies, including a safety study starting this week and a therapeutic study to follow, aim to determine Entolimod's effectiveness in supporting survival and …